Enjoy a Pain-Free Life

CRPS

Innovative New Treatment For CRPS

Complex regional pain syndrome (CRPS) is a specific form of chronic pain that often affects one arm or leg. It typically develops after an injury, stroke, heart attack, or surgery. The pain you feel can be constant and debilitating. Experts don’t understand exactly why CRPS develops, but they do know that early intervention can dramatically improve or even eliminate your pain.

Ketamine for CRPS

Ketamine is a common anesthetic that’s used for both humans and animals. When used intravenously (IV), in small doses, ketamine changes the way the brain responds to pain signals and breaks the cycle of chronic pain and gives the central nervous system a chance to recover and heal.

Some medical experts believe that CRPS may be caused by central nervous system changes, which can stimulate pain signals in your body. For example, if you stub your toe on your coffee table, it might hurt for a few minutes, but the pain eventually disappears. Unfortunately for those with CRPS, this minor pain can end up feeling extremely intense and severe.

Ketamine infusion therapy at Apex Ketamine Therapy actually blocks the NMDA receptor—a nerve cell receptor associated with pain—from firing and causing amplified pain. While some CRPS patients experience some relief with the first treatment, CRPS often requires more aggressive treatment. The experts at Apex will customize a treatment plan to your specific needs. 

FREQUENTLY ASKED QUESTIONS

Find the Answer

Ketamine is a synthetic medicine that has primarily been used as an anesthetic agent in humans and animals for over 50 years. It is one of the most commonly used anesthetic agents in the world, because of its unique properties that make it incredibly safe to administer. 

Ketamine binds to NMDA receptors, and creates a glutamate surge, releasing growth factors that help make new synaptic connections in your brain. This paves the way for healthier thought patterns and increases your resilience to chronic stress.

The literature for depression shows a 70% success rate. Individual clinics have seen higher rates, because they have seen increased efficacy with increased dosing.

The low doses used for depression are in the empathogenic "heart opening" psychedelic dose range. People report feelings of love, peace, compassion, forgiveness, and a touch of euphoria.

Ketamine will not be provided to individuals with schizophrenia, psychosis, or certain seizure disorders. Those taking aminophylline for asthma or COPD should not undergo ketamine infusions. If you have serious medical problems like uncontrolled high blood pressure, cardiac disease, or pulmonary problems, a clearance will be requested from your primary care physician before undergoing treatment.

Schedule a free consultation to learn more

Get Help
Free Consult